NEOLEUKIN THERAPEUTICS INC's ticker is and the CUSIP is 64049K954. A total of 1 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 500 | +400.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 100 | -99.9% | 0.00% | – |
| Q1 2022 | $243,000 | +1925.0% | 129,400 | +4876.9% | 0.00% | – |
| Q4 2021 | $12,000 | -72.1% | 2,600 | +8287.1% | 0.00% | – |
| Q4 2020 | $43,000 | -10.4% | 31 | -22.5% | 0.00% | – |
| Q3 2020 | $48,000 | +269.2% | 40 | +400.0% | 0.00% | – |
| Q2 2020 | $13,000 | -50.0% | 8 | -65.2% | 0.00% | – |
| Q1 2020 | $26,000 | -78.0% | 23 | -76.0% | 0.00% | – |
| Q4 2019 | $118,000 | – | 96 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |